Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mary E. Sayler"'
Autor:
Joachim F. Wernicke M.D., Mary E. Sayler, Stephanie C. Koke, Gary D. Tollefson, K R N Donna Pearson
Publikováno v:
Depression and Anxiety. 6:31-39
Concomitant use of psychoactive medications is a common practice in most clinical trials of antidepressant medications. However, the relative therapeutic impact of such use on trial results has not been the subject of much attention. We conducted a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4c09a966d81144a5ef0fed7bc9893b
https://doi.org/10.1002/(sici)1520-6394(1997)6:1<31::aid-da5>3.3.co
https://doi.org/10.1002/(sici)1520-6394(1997)6:1<31::aid-da5>3.3.co
Autor:
Mary E. Sayler, Gary D. Tollefson
Publikováno v:
Depression and Anxiety. 4:294-311
Psychomotor agitation, a common clinical feature of major depression, may first emerge or intensify during pharmacotherapy. Whether agitation is part of the underlying course of depression or iatrogenic complicates treatment planning. We analyzed dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b21f16acd5111cf70f77f057b274f7
https://doi.org/10.1002/(sici)1520-6394(1996)4:6<294::aid-da6>3.0.co
https://doi.org/10.1002/(sici)1520-6394(1996)4:6<294::aid-da6>3.0.co
Autor:
Michael G. Wilson, David J. Goldstein, Paul J. Roback, Gary D. Tollefson, Susan H. Hamilton, Alvin H. Rampey, Mary E. Sayler
Publikováno v:
Obesity Research. 3:481S-490S
Obesity is a major health care concern because of its associated medical complications and increased mortality. Despite a myriad of short-term weight loss strategies and the motivation of improving health, patients have difficulty maintaining reduced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6bf4ac8d9f76a23529257de9cc8220
https://doi.org/10.1002/j.1550-8528.1995.tb00216.x
https://doi.org/10.1002/j.1550-8528.1995.tb00216.x
Publikováno v:
Depression. 2:73-79
We investigated 243 patients from a series of comparator and/or placebo-controlled, double-blind trials of several mechanistically distinct antidepressants. Data were analyzed for changes in suicidal ideation during trial participation. Ambulatory re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44710708d7ef8608f3c95288488a1561
https://doi.org/10.1002/depr.3050020203
https://doi.org/10.1002/depr.3050020203
Autor:
Alvin H. Rampey, Janet H. Potvin, Charles M. Beasley, George Winokur, Gary D. Tollefson, Mary E. Sayler, Jan Fawcett, Douglas E. Faries
Publikováno v:
Annals of Clinical Psychiatry. 5:209-224
Double-blind, controlled clinical trial data were evaluated to assess a hypothetical relationship between fluoxetine and suicidality (suicidal acts and ideation) in patients with mood (n = 5,655) and nonmood disorders (n = 4,959) (Mantel-Haenszel inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c292da1f878b19c239e8615fb73e56
https://doi.org/10.3109/10401239309148820
https://doi.org/10.3109/10401239309148820
Autor:
Vicki L. Thompson, John H. Heiligenstein, Daniel N. Masica, Charles M. Beasley, Alvin H. Rampey, Janet C. Bosomworth, Mary E. Sayler, Bruce E. Dornseif, Dennis J. Murphy
Publikováno v:
International Clinical Psychopharmacology. 6:35-57
OBJECTIVE--A comprehensive meta-analysis of clinical trial data was performed to assess the possible association of fluoxetine and suicidality (suicidal acts and ideation). DESIGN--Retrospective analysis of pooled data from 17 double blind clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a4af49316fbc5306cb2b82099504a5
https://doi.org/10.1097/00004850-199206006-00006
https://doi.org/10.1097/00004850-199206006-00006
Publikováno v:
Journal of Affective Disorders. 20:193-200
Data regarding open-label treatment with fluoxetine following failure to respond to tricyclic antidepressants (TCAs) or intolerance of TCA side effects, suggest a response rate between 51.4% and 62.1%, depending on the definition of TCA refractorines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e57fb98fe8f686609a592e67c989eea
https://doi.org/10.1016/0165-0327(90)90144-w
https://doi.org/10.1016/0165-0327(90)90144-w
Publikováno v:
Journal of clinical psychopharmacology. 19(2)
The aim of this study was to make a preliminary investigation of the efficacy and safety of zatosetron maleate, a selective 5-hydroxytryptamine-3 receptor antagonist for patients with a broad range of anxiety symptoms. A double-blind, parallel, place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f0852495f7483d72ede8550f9e49bc
https://pubmed.ncbi.nlm.nih.gov/10211913
https://pubmed.ncbi.nlm.nih.gov/10211913
Publikováno v:
International clinical psychopharmacology. 8(3)
Fluoxetine, a serotonin uptake inhibitor, and amitriptyline, a tricyclic antidepressant, were compared in a 5-week, multicenter, double-blind, randomized trial in 136 out-patient men and women, aged 21-70 years, with major depressive disorder. Overal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30abeb5cc4b050c8f4c0a669ca62aeed
https://pubmed.ncbi.nlm.nih.gov/8263311
https://pubmed.ncbi.nlm.nih.gov/8263311
Autor:
Kenneth Koback, John H. Heiligenstein, Mary E. Sayler, Gary D. Tollefson, Sherrie L. Tollefson, John H. Greist, James W. Jefferson
Publikováno v:
Journal of Clinical Psychopharmacology. 14:385
A common presentation for major depression includes psychomotor agitation. However, this subtype has been the infrequent subject of controlled investigation during depression trials. Yet, the subcategorization of agitated depression has historically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6204c43972376abc80c13c7e72ac0514
https://doi.org/10.1097/00004714-199412000-00003
https://doi.org/10.1097/00004714-199412000-00003